Human PBMCs obtained from different healthy donors were activated in the presence of CEACAM5-expressing MKN-45 tumor cells in the presence of 2 nM of the agonistic human CD3 IgG1 antibody V9 (Figure 2B) or a titration of CEA-TCB (Figure 2C). The gene discussed is CEACAM5; the disease is neoplasm.